Research Topic

Targeting the Cell Cycle in Women’s Cancer

About this Research Topic

Cell cycle inhibitors have emerged as one of the most powerful targeted therapies beyond endocrine therapy in hormone receptor positive breast cancer. While gathering clinical information on efficacy and tolerance of these agents, further development is occurring on other disease settings and cancer types. New treatment combinations and dose schedules have been explored. Coupled with the emergence of complex molecular data identifying key molecular pathways in multiple cancer types current data supports a radically different approach to development, testing and validation of molecularly targeted therapeutics in women's cancers. We would like authors to propose new perspectives in basic, translational and clinical trials research which will accelerate the delivery of targeted therapeutics. In this Research Topic, we welcome review articles, perspectives, research articles dealing with targeted therapeutics directed against cell cycle checkpoints in women’s cancer.


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Cell cycle inhibitors have emerged as one of the most powerful targeted therapies beyond endocrine therapy in hormone receptor positive breast cancer. While gathering clinical information on efficacy and tolerance of these agents, further development is occurring on other disease settings and cancer types. New treatment combinations and dose schedules have been explored. Coupled with the emergence of complex molecular data identifying key molecular pathways in multiple cancer types current data supports a radically different approach to development, testing and validation of molecularly targeted therapeutics in women's cancers. We would like authors to propose new perspectives in basic, translational and clinical trials research which will accelerate the delivery of targeted therapeutics. In this Research Topic, we welcome review articles, perspectives, research articles dealing with targeted therapeutics directed against cell cycle checkpoints in women’s cancer.


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

13 February 2018 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

13 February 2018 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..

Comments

Loading..

Add a comment

Add comment
Back to top